BioRestorative Therapies shares are trading higher after Kaos Capital announced that it has acquired 4.9% of the issued and outstanding common stock of BioRestorative Therapies.

Benzinga Newsdesk www.benzinga.com Positive 95.1%

Neg 0% Neu 0% Pos 95.1%

Comments

No comments yet. Be the first!